- Companies
- Great Eastern Life
Great Eastern Life Valuation Multiples
Great Eastern Life is valued at $14B as of October 2026, a 1.0x revenue multiple. In the last fiscal year, Great Eastern Life revenue was $11B and Great Eastern Life EBITDA was $1.5B.
Great Eastern Life Overview
About Great Eastern Life
Great Eastern Holdings Ltd provides insurance and investment management services through three segments. The Life Insurance segment, which contributes the majority of revenue, offers life, long-term health, and accident insurance, annuities, and unit-linked products, with revenues from external customers. The Non-Life Insurance segment provides short-term property and casualty, liability, medical, and personal accident coverage, including protection against fire, burglary, and business interruption. The Shareholders segment delivers fund management services across Asia Pacific equities and fixed income portfolios for institutional clients. The company derives the majority of its revenue from Singapore.
Founded
1908
HQ
Employees
5.5K
Website
Financials (Last FY)
EV
$11B
Valuation Multiples
Start free trialGreat Eastern Life Financials
Great Eastern Life reported last fiscal year revenue of $11B and EBITDA of $1.5B.
In the same fiscal year, Great Eastern Life generated $1.5B in EBITDA and $942M in net income.
Great Eastern Life P&L
In the most recent fiscal year, Great Eastern Life reported revenue of $11B and EBITDA of $1.5B.
Great Eastern Life is profitable as of last fiscal year, with EBITDA margin of 14% and net margin of 8%.
Financial data powered by Morningstar, Inc.
Great Eastern Life Stock Performance
Great Eastern Life has current market cap of $14B, and enterprise value of $11B.
Market Cap Evolution
Great Eastern Life's stock price is $14.85.
Great Eastern Life share price decreased by 4.4% in the last 30 days, and increased by 26.7% in the last year.
Great Eastern Life has an EPS (earnings per share) of $1.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11B | $14B | -0.8% | -4.4% | -12.6% | 26.7% | $1.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGreat Eastern Life Valuation Multiples
Great Eastern Life trades at 1.0x EV/Revenue multiple, and 7.3x EV/EBITDA.
Great Eastern Life Financial Valuation Multiples
As of October 17, 2026, Great Eastern Life has market cap of $14B and EV of $11B.
Great Eastern Life has a P/E ratio of 14.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Great Eastern Life Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Great Eastern Life Margins & Growth Rates
In the most recent fiscal year, Great Eastern Life reported EBITDA margin of 14% and net margin of 8%.
Great Eastern Life Margins
Great Eastern Life Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Great Eastern Life Operational KPIs
Great Eastern Life's revenue per employee in the last FY averaged $2.0M.
Data powered by FactSet, Inc. and Morningstar, Inc.
Great Eastern Life Competitors
Great Eastern Life competitors include Taiwan Cooperative Bank, Keppel, Assurant, Insurance Australia Group, Gjensidige Forsikring, Lundbergföretagen, Omega Healthcare Investors, Annaly Capital Management, Suncorp Group and Tryg.
Most Great Eastern Life public comparables operate across Insurance Carriers and Asset Management.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $2.3B | - | 6.1x | - | - | - | |||
| $4.7B | $1.4B | 4.7x | 4.1x | 15.9x | 21.9x | |||
| $13B | $1.4B | 1.2x | 1.1x | 10.2x | 8.2x | |||
| ($17M) | $1.5B | (837.1x) | 1.1x | 9.2x | 10.0x | |||
| $4.7B | $975M | 3.0x | 2.9x | 14.3x | - | |||
| $3.1B | $1.8B | 6.2x | - | 10.8x | - | |||
| $1.2B | $1.2B | 15.2x | 16.9x | 15.5x | - | |||
| $2.2B | - | 21.0x | 19.0x | - | - | |||
This data is available for Pro users. Sign up to see all Great Eastern Life competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Great Eastern Life
Great Eastern Life has acquired 1 company to date.
Last acquisition by Great Eastern Life was on May 3rd 2019. Great Eastern Life acquired QBE Indonesia for $30M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Great Eastern Life
| Description | QBE Indonesia is a Jakarta-headquartered insurer offering property, casualty, motor, and health coverage to businesses and individuals across Indonesia. The company maintains 20 branch offices and partners with brokers serving urban centers like Surabaya and Medan. QBE Indonesia underwrites commercial risks for manufacturing and logistics firms, with products tailored to archipelago-wide distribution challenges. |
| HQ Country | |
| HQ City | Jakarta |
| Deal Date | 3 May 2019 |
| Valuation | $30M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Great Eastern Life acquisitions and their M&A valuation multiples. Start Free Trial | |
Investments by Great Eastern Life
Great Eastern Life has invested in 4 companies to date.
Latest investment by Great Eastern Life was on July 18th 2022. Great Eastern Life invested in Jiangao Pediatrics in their $12M Series A round (EV/Revenue multiple available to Pro users).
Latest Investments by Great Eastern Life
| Description | Jiangao Pediatrics is a chain of clinics across Guangdong province providing pediatric diagnosis and treatment for respiratory, digestive, and infectious conditions. Services encompass vaccinations, growth assessments, and nutritional counseling for children up to 18 years. Free community clinics operate weekly in partnership with local health bureaus. | Boost is a Kuala Lumpur-headquartered fintech company operating Malaysia's leading e-wallet and lifestyle application. Launched in 2017 as a joint venture between Axiata Digital and Razer, it serves 7.5 million users through 170,000 merchant touchpoints for payments, bill settlements, and rewards. Boost processes transactions via QR codes and NFC, integrating with public transport fares and e-commerce platforms across Southeast Asia. | uCare.ai is a healthcare AI platform founded by data scientists and physicians to predict long-term patient risks. Headquartered in Tel Aviv, the company serves patients, providers, and payers through its predictive analytics engine, which forecasts chronic disease trajectories up to a decade ahead using electronic health records and genomics data. uCare.ai collaborates with Clalit Health Services in Israel and expands to U.S. providers like Mayo Clinic affiliates, enabling personalized preventive plans and optimized insurance premiums. | China International Capital Corporation, known as CICC, is a Beijing-based investment banking and financial services group established in 1995. Its activities include investment banking, equity sales and trading, fixed income, currency and commodities services, investment management and wealth management. The company provides financial advice and capital markets services to businesses and institutions, while its wealth management operations also serve individual investors. Its investment banking activities support securities offerings, corporate transactions and access to domestic and international capital markets. Investment management services and research capabilities complement its securities and advisory businesses. CICC earns revenue through financial services, securities activities and the management of client investments rather than manufacturing or selling physical products. The company converted into a joint stock company in June 2015 and listed on the Hong Kong Stock Exchange in November of that year. |
| HQ Country | ||||
| HQ City | Shanghai | Kuala Lumpur | Singapore | Beijing |
| Deal Date | 18 Jul 2022 | 25 Jun 2020 | 16 May 2018 | 1 Dec 2010 |
| Round | Series A | Strategic investment | Series A | Strategic investment |
| Raised | $12M | $70M | $6M | undisclosed |
| Investors | Great Eastern Life | Great Eastern Life | Walden International; Great Eastern Life; Peter Lim; WPGrowth Ventures | KKR; GIC; Great Eastern Life; TPG |
| Valuation | undisclosed | $1.5B | $44M | undisclosed |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all Great Eastern Life investments and their VC round multiples. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Great Eastern Life
| When was Great Eastern Life founded? | Great Eastern Life was founded in 1908. |
| Where is Great Eastern Life headquartered? | Great Eastern Life is headquartered in Singapore. |
| How many employees does Great Eastern Life have? | As of today, Great Eastern Life has over 5K employees. |
| Is Great Eastern Life publicly listed? | Yes, Great Eastern Life is a public company listed on Singapore Exchange. |
| What is the stock symbol of Great Eastern Life? | Great Eastern Life trades under G07 ticker. |
| When did Great Eastern Life go public? | Great Eastern Life went public in 1999. |
| Who are competitors of Great Eastern Life? | Great Eastern Life main competitors include Taiwan Cooperative Bank, Keppel, Assurant, Insurance Australia Group, Gjensidige Forsikring, Lundbergföretagen, Omega Healthcare Investors, Annaly Capital Management, Suncorp Group, Tryg. |
| What is the current market cap of Great Eastern Life? | Great Eastern Life's current market cap is $14B. |
| What is the current revenue of Great Eastern Life? | Great Eastern Life's last fiscal year revenue is $11B. |
| What is the current EV/Revenue multiple of Great Eastern Life? | Current revenue multiple of Great Eastern Life is 1.0x. |
| Is Great Eastern Life profitable? | No, Great Eastern Life is not profitable. |
| How many companies Great Eastern Life has acquired to date? | As of October 2026, Great Eastern Life has acquired 1 company. |
| What was the largest acquisition by Great Eastern Life? | $30M acquisition of QBE Indonesia on 3rd May 2019 was the largest M&A Great Eastern Life has done to date. |
| What companies Great Eastern Life acquired? | Great Eastern Life acquired QBE Indonesia. |
| In how many companies Great Eastern Life has invested to date? | As of October 2026, Great Eastern Life has invested in 4 companies. |
| What was the last Great Eastern Life investment? | On 18th July 2022 Great Eastern Life invested in Jiangao Pediatrics, participating in a $12M Series A round. |
| In what companies Great Eastern Life invested in? | Great Eastern Life invested in Boost, Jiangao Pediatrics, uCare.ai, and CICC. |
See public comps similar to Great Eastern Life
Lists including Great Eastern Life
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




